Lopinavir/r no longer recommended as a first-line regimen: a comparative effectiveness analysis

INTRODUCTION: We compared the effectiveness of tenofovir/emtricitabine (TDF/FTC) combined with either lopinavir/r (LPV/r) or another recommended third drug in the 2010 French guidelines in antiretroviral-naïve patients starting combination antiretroviral therapy in 2004–2008 in the French Hospital D...

Descripción completa

Detalles Bibliográficos
Autores principales: Potard, Valérie, Rey, David, Poizot-Martin, Isabelle, Mokhtari, Saadia, Pradier, Christian, Rozenbaum, Willy, Brun-Vezinet, Françoise, Costagliola, Dominique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176690/
https://www.ncbi.nlm.nih.gov/pubmed/25261780
http://dx.doi.org/10.7448/IAS.17.1.19070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176690/
https://www.ncbi.nlm.nih.gov/pubmed/25261780
http://dx.doi.org/10.7448/IAS.17.1.19070

Ejemplares similares